Electrolytic complexing of glucoheptonate and technetium-99m

Area of Science:

• Radiochemistry
• Nuclear Medicine
• Analytical Chemistry

Background:

• Technetium-99m (Tc-99m) radiopharmaceuticals are crucial in nuclear medicine imaging.
• Efficient and stable labeling of Tc-99m is essential for diagnostic accuracy.
• Current commercial Tc-99m agents have limitations in stability and cost.

Purpose of the Study:

• To optimize an electrolytic method for labeling sodium pertechnetate (Tc-99m) with glucoheptonate.
• To evaluate the radiochemical purity, efficiency, and stability of the Tc-99m glucoheptonate complex.
• To compare the developed method with commercially available Tc-99m (Sn) glucoheptonate.

Main Methods:

• Electrolysis of sodium pertechnetate (Tc-99m) and calcium glucoheptonate at varying ampere-time products.
• Radiochemical purity determination using a two-solvent thin-layer chromatography system (methyl-ethyl ketone and normal saline).
• Assessment of tagging efficiency and complex stability via chromatographic analysis.

Main Results:

• A charge of 9 coulombs (100 mA, 90 sec) consistently yielded >90% tagging efficiency.
• The final product exhibited <10% total radiochemical impurities.
• The Tc-99m calcium glucoheptonate complex demonstrated superior stability compared to Tc-99m (Sn) glucoheptonate.

Conclusions:

• Electrolytic labeling with Tc-99m calcium glucoheptonate is a rapid, efficient, and cost-effective method.
• The developed method produces a radiopharmaceutical with high purity and stability.
• This process offers a viable, potentially superior alternative to commercial Tc-99m (Sn) glucoheptonate for medical applications.